Congenital adrenal hyperplasia is usually treated with steroid hormones, but these can inhibit growth when administered at high doses, especially during early to mid-adolescence. A retrospective observational study identifies the dose of glucocorticoids that should be used to maximize pubertal growth while achieving desired height.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bonfig, W. et al. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence based recommendation. J. Clin. Endocrinol. 94, 3882–3888 (2009).
Hargitai, G. et al. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency: results of a multicenter study. Horm. Res. 55, 161–171 (2001).
Punthakee, Z., Legault, L. & Polychronakos, C. Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. J. Pediatr. 143, 402–405 (2003).
Rivkees, S. A. & Crawford, J. D. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 106, 767–773 (2000).
Aycan, Z. et al. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential. J. Pediatr. Endocrinol. Metab. 19, 245–251 (2006).
Jääskeläinen, J. & Voutilainen, R. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatr. Res. 41, 30–33 (1997).
Silva, I. N., Kater, C. E., Cunha, C. F. & Viana, M. B. Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia. Arch. Dis. Child. 77, 214–218 (1997).
Clayton, P. E. et al. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and The European Society for Pediatric Endocrinology. J. Clin. Endocrinol. Metab. 87, 4048–4053 (2002).
Merke, D. P. et al. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 85, 1114–1120 (2000).
Lin-Su, K. et al. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 90, 3318–3325 (2005).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Speiser, P. Congenital adrenal hyperplasia—glucocorticoids and height. Nat Rev Endocrinol 6, 14–15 (2010). https://doi.org/10.1038/nrendo.2009.242
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2009.242
